The world’s top selling drug, a cholesterol fighter, does not show to help children overcome a learning disability that common and genetically linked. Past studies with lab mice showed that simvastatin helped the learning and attention deficits caused by neurofibromatosis 1, a disorder that alters activity in the brain. However, a more recent test by Lianna Krab of Erasmus MC University Medical Center, Sophia Childrens’ Hospital, Rotterdamn, The Netherlands says that a test of the drug on 62 children with the condition did not help. Neurofibromatosis 1 affects memory, motor skills, and general cognitive disabilities by causing tumors involving nerve tissue. This condition affects one in every 3,000 children.

          Children in the study were given either the drug simvastatin or an inert placebo for three months. According to the report published in the Journal of the American Medical Association, "Simvastin did not improve cognitive function in children" with the disorder and should not be suggested for that use.

           If you or a loved one has been harmed by a dangerous drug or product, contact the personal injury lawyers at Cappolino Dodd Krebs LLP today, at 1-800-460-0606.